Dr. Steven R. Goldsmith, MD

Dr. Goldsmith practices at Hennepin County Medical Center in Minneapolis, Minnesota, part of Hennepin County.

Dr. Goldsmith's NPI, 1285673947, was assigned on June 6, 2006. Dr. Goldsmith graduated from Ohio State University College of Medicine in 1975. Dr. Goldsmith holds Minnesota license 24291.

Dr. Goldsmith's primary practice is Hennepin County Medical Center, at 701 Park Avenue, Minneapolis, MN 55415 in Hennepin County. The practice phone is (612) 873-3000.

Dr. Goldsmith's primary practice is Hennepin County Medical Center in Minneapolis, Minnesota, part of Hennepin County. The medical group on file is Hennepin Healthcare. Dmand AI also links Dr. Goldsmith to 1 more group practice or clinic, named with a free account. Dr. Goldsmith's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Goldsmith practices, 2 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Goldsmith's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Goldsmith is licensed in Minnesota.

CMS data shows 244 Medicare services from Dr. Goldsmith across 5 procedure codes in 2024, for 231 Medicare patients. Medicare paid $7,768 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 231 Medicare patients who saw Dr. Goldsmith in 2024. The largest group is under 65, with 80 patients. 75% of them have high blood pressure, and 67% have high cholesterol. 60% are also on Medicaid. Their average risk score is 3.08, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Goldsmith's median patient age at 60, with 43% women.

In 2024, Dr. Goldsmith wrote 364 Medicare Part D claims for 90 patients. 70% of them were for generic drugs. CMS names the drug for 246 of them, across 11 drugs with 11 or more claims each, at $69,380 in total drug cost. In 2023, CMS named 466 claims across 15 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Goldsmith for performance year 2024, reported as part of a group. Dr. Goldsmith accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 36 papers to Dr. Goldsmith, published from 2011 to 2022. 2016 was the busiest year, with 4. The most frequent topics are Heart Failure, Antidiuretic Hormone Receptor Antagonists and Benzazepines. Dr. Goldsmith has published most often in J Card Fail. Dr. Goldsmith's most frequent co-authors are Bradley A. Bart, MD, Margaret M. Redfield, MD and Christopher M. O'Connor.

CMS Open Payments shows 309 general payments to Dr. Goldsmith from 10 drug and device companies from 2016 to 2023. Speaker and faculty fees make up the largest share, 54% of the total. Otsuka America Pharmaceutical, Inc. paid the most, $115,615.

Dr. Goldsmith graduated from Ohio State University College of Medicine in 1975.